Skip to content

Urine-based bladder cancer screening in hematuria population

Urine-based bladder cancer screening in hematuria population

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040337
Enrollment
Unknown
Registered
2020-11-28
Start date
2020-11-30
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

baldder cancer

Interventions

Gold Standard:Pathological examination
markers&#32
based&#32
on&#32
for&#32
cancer

Sponsors

Shanghai Minhang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Hematuria group: 1) Aged 18-90 years old; 2) No history of malignant tumor; 3) Urine routine suggested hematuria; 4) Subjects must provide informed consent prior to any study specific procedure; Control group: 1) aged 18-90 years old; 2) No history of malignant tumor diseases; 3) Subjects must provide informed consent prior to any study specific procedure.

Exclusion criteria

Exclusion criteria: Hematuria group: 1) Unnatural urination; 2) Patients whose morning urine was collected; 3) Urine sample less than 50ml; Control group: 1) Unnatural urination; 2) Patients whose morning urine was collected; 3)Urine sample less than 50ml.

Design outcomes

Primary

MeasureTime frame
SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactShi Qihui

Shanghai Minhang Central Hospital

qihuishi@fudan.edu.cn+86 19512394626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026